Adaptive Biotechnologies vs Cellcolabs
Adaptive Biotechnologies vs Cellcolabs, compared side by side on 12 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Adaptive Biotechnologies is on 69/100 and Cellcolabs on 55/100.
Where each one leads
Adaptive Biotechnologies
- our overall score: 69/100 against 55/100
- domain rating: 61/100 against 37/100
- funding raised: $300M against $15.5M
Cellcolabs
Leads on none of the measures we hold for both companies.
At a glance
| Measure | Adaptive Biotechnologies | Cellcolabs |
|---|---|---|
| What it is | Leveraging the adaptive immune system to diagnose and treat disease. | AI-powered platform for personalized cell therapy development and manufacturing. |
| Category | Biotech, HealthTech, Genomics, Drug Discovery | Biotech, MedTech, HealthTech, Drug Discovery |
| Sells toBusiness model | B2B | B2B |
| Offering | Software | services | platform | Platform |
| Founded | 2009 | 2021 |
| Headquarters | Seattle, United States | Tel Aviv, Israel |
| Status | Active | Active |
Size, funding and growth
| Measure | Adaptive Biotechnologies | Cellcolabs |
|---|---|---|
| Employees | Not published | 79 |
| Total funding | $300M | $15.5M |
| Latest round | Series D | Not published |
| LinkedIn followers | Not published | 6,563 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Adaptive Biotechnologies | Cellcolabs |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 69/100 | 55/100 |
| Search visibility | Not published | 2/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (39/100) | D (40/100) |
| Domain ratingLink authority, 0-100 | 61/100 | 37/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Adaptive Biotechnologies | Cellcolabs |
|---|---|---|
| Hosting | Self Managed | Not detected |
| CDN | Not detected | Cloudflare |
| CMS | WordPress | Not detected |
| Frameworks | Jquery | Not detected |
| Analytics | Google Tag Manager | Google Tag Manager |
Adaptive Biotechnologies vs Cellcolabs: common questions
Which is better, Adaptive Biotechnologies or Cellcolabs?
On our 0-100 score Adaptive Biotechnologies rates higher (69/100 against 55/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 12 data points above: read the rows that match what you are buying for.
How do Adaptive Biotechnologies and Cellcolabs compare on the numbers?
Adaptive Biotechnologies leads on our overall score (69/100 against 55/100), domain rating (61/100 against 37/100), funding raised ($300M against $15.5M).
Read the full Adaptive Biotechnologies review and pricing or the Cellcolabs review and pricing. You can also browse other Adaptive Biotechnologies alternatives we track.